Evidence map›Paper›PMID 40336646›Full record

ArticlePrecision radiation oncology2024

Evolution of dose distribution for a

Hosein Poorbaygi, Elham Sardari, Seyed Mahmoud Reza Aghamiri, Shahab Sheibani, Mojtaba Arjmand, Somayeh Moradi, Fariba Ghassemi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Precision radiation oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Editorial: 2Precision radiation oncology · 2025
    Article
  2. Evolution of dose distribution for aPrecision radiation oncology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hosein PoorbaygiRadiation Application Research School Nuclear Science and Technology Tehran Iran.ORCID https://orcid.org/0000-0001-9644-8587
Elham SardariDepartment of Radiation Medicine Shahid Beheshti University Tehran Iran.
Seyed Mahmoud Reza AghamiriDepartment of Radiation Medicine Shahid Beheshti University Tehran Iran.
Shahab SheibaniRadiation Application Research School Nuclear Science and Technology Tehran Iran.
Mojtaba ArjmandOcular Oncology Service Farabi Eye Hospital Tehran Iran.
Somayeh MoradiRadiation Application Research School Nuclear Science and Technology Tehran Iran.
Fariba GhassemiOcular Oncology Service Farabi Eye Hospital Tehran Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Eye plaque radiation therapy is the treatment of choice for small- and medium-sized choroidal melanomas. This study investigated the dose distribution around eye plaques containing Methods: Dosimetry evaluation and comparison of the resulting isodose curves for Results: In the validation, the maximum relative difference between the results of this study and those reported in other literature was approximately 9%-10% for the COMS plaques. The dose distributions of MCNPX were lower than those of PS with a relative difference of approximately 27.7%-35.4%. The dose distribution may differ depending on the Conclusion: The PS did not provide accurate details of dose distribution near the surface of the plaque insert. The source parameters used in each program should be studied more carefully to determine the source of the differences in the estimated dose values.

Indexed as

125I seeddosimetry calculationEye plaqueMonte Carlo N‐Particle eXtended (MCNPX)treatment planning system

Identifiers

PMID40336646
PMCPMC11934971

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.